PPARA and metabolic dysfunction-associated steatotic liver disease: As regarding to NAFLD, Guo et al. (Guo et al., 2018) found that circRNA_0046366 abolished the inhibitory effect of miR-34a on PPAR, and then improved the steatosis-related triglyceride metabolism.